A Mediterranean Low-Glycemic-Load Diet alone or in Combination with a Medical Food Improves Insulin Sensitivity and Reduces Inflammation in Women with Metabolic Syndrome

References (57)

1. 1 Obesity is associated with macrophage accumulation in adipose tissue [DOI]
2. 2 Adipokines in inflammation and metabolic disease [DOI]
3. 3 A comprehensive definition for metabolic syndrome [DOI]
4. 4 Obesity, Inflammation, and Insulin Resistance [DOI]
5. 5 Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk [DOI]
6. 6 Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome [DOI]
7. 7 Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006.
8. 8 Adiponectin as a Biomarker of the Metabolic Syndrome [DOI]
9. 9 Minireview: Adiposity, Inflammation, and Atherogenesis [DOI]
10. 10 Is visceral obesity the cause of the metabolic syndrome? [DOI]
11. 11 Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades [DOI]
12. 12 Adipose Tissue: The New Endocrine Organ? A Review Article [DOI]
13. 13 Adipokines as emerging mediators of immune response and inflammation [DOI]
14. 14 The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases [DOI]
15. 15 Screening for Obesity in Adults: Recommendations and Rationale [DOI]
16. 16 Insulin resistance and the metabolic syndrome [DOI]
17. 17 Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes [DOI]
18. 18 Insulin Resistance in Obesity as the Underlying Cause for the Metabolic Syndrome [DOI]
19. 19 Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk [DOI]
20. 20 Adipokines as novel modulators of lipid metabolism [DOI]
21. 21 Adiponectin: A Key Player in Obesity Related Disorders [DOI]
22. 22 Insulin Resistance, Insulin Response, and Obesity as Indicators of Metabolic Risk [DOI]
23. 23 Mediterranean diet and metabolic syndrome: the evidence [DOI]
24. 24 The link between abdominal obesity and the metabolic syndrome [DOI]
25. 25 Role of adipokines in complications related to obesity. A review [DOI]
26. 26 Dietary patterns and metabolic syndrome--a review of epidemiologic evidence.
27. 27 Obesity, Abdominal Obesity, and Insulin Resistance [DOI]
28. 28 White adipose tissue and cardiovascular disease [DOI]
29. 29 Obesity, metabolic syndrome, adipocytes and vascular function: A holistic viewpoint [DOI]
30. 30 Muscle insulin resistance: assault by lipids, cytokines and local macrophages [DOI]
31. 31 The Mediterranean diet revisited: evidence of its effectiveness grows [DOI]
32. 32 Fat distribution and storage: how much, where, and how? [DOI]
33. 33 Beyond Obesity: The Diagnosis and Pathophysiology of Metabolic Syndrome [DOI]
34. 34 Leptin-Signaling Pathways and Leptin Resistance [DOI]
35. 35 The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review [DOI]
36. 36 Impact of HDL on adipose tissue metabolism and adiponectin expression [DOI]
37. 37 Adipose tissue as an endocrine organ: implications of its distribution on free fatty acid metabolism [DOI]
38. 38 Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial [DOI]
39. 39 A Mediterranean-style low-glycemic-load diet improves variables of metabolic syndrome in women, and addition of a phytochemical-rich medical food enhances benefits on lipoprotein metabolism [DOI]
40. 40 Obesity and cardiovascular disease: is body structure a factor? [DOI]
41. 41 Endocrine Diseases and the Liver [DOI]
42. 42 Obesity on the Rise [DOI]
43. 43 Diet‐induced Changes in Intra‐abdominal Adipose Tissue and CVD Risk in American Women [DOI]
44. 44 Elevated soluble intercellular adhesion molecule-1 levels in obesity: Relationship to insulin resistance and tumor necrosis factor-[alpha ] system activity [DOI]
45. 45 Insulin resistance and the metabolic syndrome.
46. 46 Obesity and Metabolic Disease [DOI]
47. 47 A Science-Based, Clinically Tested Dietary Approach for the Metabolic Syndrome [DOI]
48. 48 Implications of the biology of weight regulation and obesity on the treatment of obesity [DOI]
49. 49 Modest weight loss does not increase plasma adiponectin levels: effects of weight loss on C-reactive protein and DNA damage [DOI]
50. 50 Effect of regional fat loss assessed by DXA on insulin resistance and dyslipidaemia in obese women [DOI]
51. 51 Harmonizing the Metabolic Syndrome [DOI]
52. 52 Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage [DOI]
53. 53 The Effect of Mediterranean Diet on Metabolic Syndrome and its Components [DOI]
54. 54 Metabolic Implications of Body Fat Distribution [DOI]
55. 55 Vascular biology of metabolic syndrome [DOI]
56. 56 Diet and Metabolic Syndrome [DOI]
57. 57 Total adiponectin and adiponectin multimeric complexes in relation to weight loss-induced improvements in insulin sensitivity in obese women: the NUGENOB study. [DOI]

Cited by 13

Showing 6 of 13 known citations — external sources report more than can currently be individually listed.

Related research

• Metabolic Syndrome among Healthcare Workers in a Tertiary Hospital in South-South, Nigeria — shares topic coverage
• Cortisol and Metabolic Syndrome Components in Obese and Overweight Young Adults of a Nigerian Private University — shares topic coverage
• Metabolic Syndrome and Kidney Damage: Prevalence and Assessment of Risk among Apparently Healthy Resident of Ado Ekiti, South West Nigeria — shares topic coverage
• Vitamin D and Insulin Resistance in Metabolic Syndrome — shares topic coverage
• Metabolic Syndrome and Its Association with Nutritional and Cardiometabolic Risk Factors: Prevalence among Apparently Healthy Adults in a Rural Community in Southwestern Nigeria — shares topic coverage